ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Short Interest Update

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) was the recipient of a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 8,600 shares, a growth of 32.3% from the October 31st total of 6,500 shares. Based on an average trading volume of 14,800 shares, the short-interest ratio is presently 0.6 days.

Hedge Funds Weigh In On ProShares UltraShort Nasdaq Biotechnology

An institutional investor recently bought a new position in ProShares UltraShort Nasdaq Biotechnology stock. Jane Street Group LLC purchased a new stake in shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 10,520 shares of the company’s stock, valued at approximately $158,000. Jane Street Group LLC owned 4.78% of ProShares UltraShort Nasdaq Biotechnology as of its most recent SEC filing.

ProShares UltraShort Nasdaq Biotechnology Price Performance

NASDAQ:BIS traded up $0.02 on Friday, reaching $15.83. The stock had a trading volume of 7,255 shares, compared to its average volume of 14,023. ProShares UltraShort Nasdaq Biotechnology has a 1-year low of $14.05 and a 1-year high of $23.42. The stock has a fifty day moving average price of $15.58 and a 200-day moving average price of $15.81.

ProShares UltraShort Nasdaq Biotechnology Cuts Dividend

The firm also recently declared a dividend, which was paid on Wednesday, October 2nd. Investors of record on Wednesday, September 25th were issued a dividend of $0.1518 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

About ProShares UltraShort Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.